全文获取类型
收费全文 | 25504篇 |
免费 | 2588篇 |
国内免费 | 1012篇 |
专业分类
耳鼻咽喉 | 437篇 |
儿科学 | 166篇 |
妇产科学 | 406篇 |
基础医学 | 2443篇 |
口腔科学 | 561篇 |
临床医学 | 1809篇 |
内科学 | 2310篇 |
皮肤病学 | 300篇 |
神经病学 | 683篇 |
特种医学 | 1128篇 |
外国民族医学 | 37篇 |
外科学 | 4211篇 |
综合类 | 3660篇 |
现状与发展 | 8篇 |
预防医学 | 512篇 |
眼科学 | 193篇 |
药学 | 1190篇 |
5篇 | |
中国医学 | 383篇 |
肿瘤学 | 8662篇 |
出版年
2024年 | 55篇 |
2023年 | 423篇 |
2022年 | 896篇 |
2021年 | 1139篇 |
2020年 | 962篇 |
2019年 | 852篇 |
2018年 | 811篇 |
2017年 | 916篇 |
2016年 | 1054篇 |
2015年 | 1354篇 |
2014年 | 1671篇 |
2013年 | 1505篇 |
2012年 | 1461篇 |
2011年 | 1589篇 |
2010年 | 1313篇 |
2009年 | 1287篇 |
2008年 | 1323篇 |
2007年 | 1308篇 |
2006年 | 1255篇 |
2005年 | 1174篇 |
2004年 | 943篇 |
2003年 | 849篇 |
2002年 | 710篇 |
2001年 | 599篇 |
2000年 | 554篇 |
1999年 | 480篇 |
1998年 | 449篇 |
1997年 | 342篇 |
1996年 | 248篇 |
1995年 | 220篇 |
1994年 | 186篇 |
1993年 | 131篇 |
1992年 | 119篇 |
1991年 | 85篇 |
1990年 | 77篇 |
1989年 | 66篇 |
1988年 | 62篇 |
1987年 | 54篇 |
1986年 | 38篇 |
1985年 | 104篇 |
1984年 | 73篇 |
1983年 | 66篇 |
1982年 | 57篇 |
1981年 | 73篇 |
1980年 | 69篇 |
1979年 | 67篇 |
1978年 | 13篇 |
1977年 | 8篇 |
1976年 | 3篇 |
1972年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Paula S. Ginter M.D. Edyta C. Pirog M.D. Ph.D. Rana S. Hoda M.D. F.I.A.C. 《Diagnostic cytopathology》2015,43(9):756-762
High grade endometrial stromal sarcoma (HGESS) is an uncommon malignancy recently re‐defined in the new WHO classification of endometrial stromal tumors. In this article, we discuss the differential diagnoses of metastatic HGESS in a fine needle aspiration (FNA) of a lymph node and compare the cytomorphology of HGESS in ThinPrep [(TP), Hologic Inc., Boxborough, MA] to conventional smears (CS). The patient had a history of stage I HGESS, status‐post supracervical hysterectomy without regional lymph node metastases. Her post‐operative course was complicated by pelvic fluid collections and enlarging para‐aortic lymph nodes. Diff‐Quik (DQ)‐stained and Papanicolaou (Pap)‐stained smears from a para‐aortic lymph node FNA demonstrated a cellular specimen with monomorphic population of plump to oval cells with scant, wispy cytoplasm in aggregates and as single cells. The nuclei showed fine chromatin and small inconspicuous nucleoli. Compared to the CS, HGESS cells in the TP showed similar cytological features, with the exception that the nuclei were slightly smaller, hyperchromatic, and the chromatin pattern was attenuated. In the absence of prior clinical history, the cytomorphology of metastatic HGESS in a lymph node can be difficult to differentiate from a lymphoma, a variety of metastatic spindle cell tumors or metastatic carcinoma. Immunohistochemical analysis and comparison with the primary tumor can be useful in proving the nature of the malignant cells. The cytomorphology of HGESS on TP correlated well in both single cells and aggregates when compared to CS. The differences noted were decreased nuclear size, nuclear hyperchromasia, and slightly attenuated nuclear detail on TP. Diagn. Cytopathol. 2015;43:756–762. © 2015 Wiley Periodicals, Inc. 相似文献
992.
Hongjiang Liu Zhongqiang Lv Erkun Guo 《International journal of clinical and experimental pathology》2015,8(8):9140-9146
Long noncoding RNAs (lncRNAs), a class of ribonucleic molecules, participate in various cellular processes. They are highly expressed in several types of cancer and their expression was related to pathophysiological characteristics of tumor growth, therefore, they can be considered as a promising diagnostic tool and a convenient prognostic biomarker. SPRY4-IT1, belonging to a group of intron-retained lncRNAs, was reported to affect tumor development of many types of cancer. However, the expression and the role of SPRY4-IT1 in glioma are still unclear. Therefore, in this study, we examined for the first time the expression and role of SPRY4-IT1 in glioma cells. The results of our study showed that SPRY4-IT1 was up-regulated in human glioma tissues and cell lines. Knockdown of SPRY4-IT1 could inhibit glioma cell growth and migration. Moreover, knockdown of SPRY4-IT1 could inhibit epithelial-mesenchymal transition (EMT) phenotype in glioma cells. Based on these findings, SPRY4-IT1 may be used as a new target for diagnosis and treatment of glioma. 相似文献
993.
Yan-Wei Shen Yan-Xia Sui Xiao-Man Zhang Meng Lv Xiao Zhang Pei-Jun Liu Jin Yang 《International journal of clinical and experimental pathology》2015,8(8):9647-9654
Metastases to the breast from extramammary malignancies are extremely rare. Ruling out the diagnosis of primary breast tumor is important in order to decide on clinical management and predict prognosis. We report a case of metastasis to the breast from a pulmonary adenocarcinoma, with extensive micropapillary component, diagnosed concomitantly with the primary tumor. A 52 year-old female patient presented with mammary gland tingling and dyspnea accompanied with fatigued of 4 months duration and a nodular shadows in the front of the upper lobe was found on a chest computed tomography (CT) scan. The original clinical diagnosis was right breast cancer with lung and bone metastasis, or breast and lung double primary cancers. In addition,on physical examination a poorly defined mass was noted in the upper outer quadrant of the right breast. The patient underwent thoracocentesis and breast biopsy. By imageology, cytology, histology and immunohistochemistry, we diagnosed primary lung cancer with metastases to the right breast and bone. The metastatic anatomic sites demonstrated histologically extensive micropapillary component, which is recently recognized as an important prognostic factor. The patient was administered 4 cycles of cisplatin and docetaxel, although no clinical response was seen, the patient is still alive 9 months after diagnosis. The result of immunohistochemistry is a useful supplement in differential diagnosis. 相似文献
994.
995.
腹膜是结直肠癌转移的好发部位。结直肠癌发生腹膜转移长期以来被认为预后很差,主要采用姑息性手段治疗。尽管化疗及靶向治疗在结直肠癌治疗上有很大进展,但对于腹膜转移的结直肠癌疗效并不理想。最近越来越多的证据表明,肿瘤细胞减灭术(CRS)联合腹腔内热灌注化疗(HIPEC)的治疗方法能给这部分患者带来较大的生存获益。本文综述了结直肠癌腹膜转移的诊治现状和相关进展。目前认为CRS联合HIPEC对选择的结直肠癌腹膜转移患者是一种安全有效的治疗模式,但HIPEC能否预防进展期结直肠癌发生腹膜转移,还有待进一步的临床试验研究。 相似文献
996.
Makoto Endoh Satoshi Shiono Yoshikane Yamauchi Mingyon Mun Norihiko Ikeda Hiroshi Hashimoto Hirotoshi Horio Hisao Asamura Ichiro Yoshino Haruhisa Matsuguma Jun Nakajima Takahiko Oyama Yasushi Shintani Mitsuo Nakayama Noriyuki Matsutani Masafumi Kawamura 《Journal of thoracic disease》2020,12(11):6552
BackgroundPulmonary metastasectomy (PM) for breast cancer-derived pulmonary metastasis is controversial. This study aimed to assess the prognostic factors and implication of PM for metastatic breast cancer using a multi-institutional database.MethodsClinical data of 253 females with pulmonary metastasis of breast cancer who underwent PM between 1982 and 2017 were analyzed retrospectively.ResultsThe median patient age was 56 years. The median follow-up period was 5.4 years, and the median disease-free interval (DFI) was 4.8 years. The 5- and 10-year survival rates after PM were 64.9% and 50.4%, respectively, and the median overall survival was 10.1 years. Univariate analysis revealed that the period of PM before 2000, a DFI <36 months, lobectomy/pneumonectomy, large tumor size, and lymph node metastasis were predictive of a worse overall survival. In the multivariate analysis, a DFI <36 months, large tumor size, and lymph node metastasis remained significantly related to overall survival. The 5- and 10-year cancer-specific survival rates after PM were 66.9% and 54.7%, respectively, and the median cancer-specific survival was 13.1 years. Univariate analyses revealed that the period of PM before 2000, DFI <36 months, lobectomy/pneumonectomy, large tumor size, lymph node metastasis, and incomplete resection were predictive of a worse cancer-specific survival. Multivariate analysis confirmed that a DFI <36 months, large tumor size and incomplete resection were significantly related to cancer-specific survival.ConclusionsAs PM has limited efficacy in breast cancer, it should be considered an optional treatment for pulmonary metastasis of breast cancer. 相似文献
997.
目的 建立胰腺癌伴神经浸润的动物模型.方法 32只裸鼠分为4组,每组8只.将人胰腺癌细胞SW1990、CAPAN-2、PANC1分别注射于裸鼠的坐骨神经周围,以不做任何处理的裸鼠作为对照组.观察术后裸鼠体质量变化、成瘤情况、成瘤时间、造模成功率等指标.结果 对照组裸鼠体质量增加,各癌细胞注射组裸鼠成瘤后体质量明显下降,甚至呈现恶液质,成瘤侧肢体活动受限.CAPAN-2注射组及SW1990注射组的8只裸鼠最终均成瘤,PANC1注射组只有5只成瘤.以肿瘤最长径长至约0.8 cm为时间截点,CAPAN-2注射组、PANC1注射组、SW1990注射组裸鼠的成瘤时间分别为(49.8±5.0)、(56.6±2.4)、(25.4±3.0)d.SW1990注射组成瘤时间最短,PANC1注射组成瘤时间最长,3组间成瘤时间的差异具有统计学意义(F=73.51,P<0.01).CAPAN-2注射组、PANC1注射组、SW1990注射组裸鼠神经浸润造模成功率分别为87.5% (7/8)、20.0%(1/5)、50.0% (4/8).结论 成功建立了胰腺癌伴神经浸润动物模型,但不同的胰腺癌细胞系建立的动物模型具有不同的特点. 相似文献
998.
Y. Baba M. Watanabe K. Kawanaka S. Iwagami T. Ishimoto M. Iwatsuki N. Yoshida Y. Yamashita H. Baba 《Diseases of the esophagus》2014,27(1):36-41
Radiofrequency ablation (RFA) is increasingly being used for the treatment of intrathoracic malignancies. Although RFA has been found to be promising in the treatment of lung metastases from some types of neoplasms, little is known concerning its clinical significance in the treatment of pulmonary metastasis from esophageal squamous cell carcinoma (ESCC). This retrospective study evaluated the feasibility, safety, and effectiveness of computed tomography‐guided RFA for pulmonary metastasis from ESCC. A series of 10 ESCC patients with 17 pulmonary tumors were included. Correct placement of the ablation device into the target tumor proved to be feasible in all tumors (100%). The mean visual analog scale score, with values that ranged from 0 (no pain) to 10 (worst pain possible), was 1. This suggested that this procedure was well tolerated. No procedure‐related deaths occurred. A pneumothorax needing drainage was a major complication in two patients. Local control of ablated tumor lasting for at least 1 year was achieved in 10 (83%) of 12 assessable tumors. Although locoregional recurrences developed in two tumors, these lesions could be recontrolled by repeat treatment with RFA. Three patients died of recurrent disease. The predicted 1‐ and 2‐year overall survival rates after lung RFA were 77.8% and 62.2%, respectively. Percutaneous computed tomography‐guided RFA yielded relatively high levels of local control in patients with pulmonary metastases from ESCC and was associated with an acceptable level of complications. It was concluded that a prospective study will be necessary to evaluate the effectiveness of a combination of systemic therapy and RFA for ESCC lung metastases. 相似文献
999.
Murad Aljiffry Mawaddah Alrajraji Salman Al-Sabah Mazen Hassanain 《Saudi Journal Of Gastroenterology》2014,20(5):315-318
Laparoscopic approaches have been increasingly used in selected patients with either colorectal or liver cancer. However, simultaneous resection of colorectal carcinoma with synchronous liver metastases is still a subject of debate. The present case describes combined laparoscopic rectal and liver resections for a patient with primary rectal cancer and a synchronous liver metastasis utilizing a Pfannenstiel incision for specimen extraction. The operative time was 370 min and estimated blood loss was 400 mL. Postoperatively, the patient required parenteral analgesia for 48 h, resumed normal diet on day 3 and was discharged on day 7 after the operation. A laparoscopic approach utilizing a Pfannenstiel extraction incision may present an advantageous and attractive option for simultaneous laparoscopic rectal and liver resection in selected patients with the aim of improving short-term outcomes. 相似文献